Pharmaceutical

SyntheticGestalt and Enamine partner on AI drug discovery models

SyntheticGestalt and Enamine have announced a collaboration to develop a suite of AI models to aid in the discovery of drugs.

Jan 13, 2024 - 18:00
SyntheticGestalt and Enamine partner on AI drug discovery models
SyntheticGestalt and Enamine have announced a collaboration to develop a suite of AI models to aid in the discovery of drugs.
Read the original article

Tags:

Previous Article

Cereno partners with CordenPharma to scale up CS1 drug production

Next Article

Q&A: Exploring the challenges behind oncology trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Idorsia introduces Quviviq in Switzerland for chronic insomnia treatment

Idorsia introduces Quviviq in Switzerland for chronic i...

Jun 13, 2023

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Scottish company secures £4.2m to advance 3D-printed mi...

Feb 2, 2024

CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Li...

Aug 10, 2023